Biological Markers to Differentiate the Subtypes of Depression

2017 ◽  
pp. 115-128
Author(s):  
Je-Yeon Yun ◽  
Seung-Hwan Lee
Keyword(s):  
Biological Markers

Extreme self-sacrifice beyond fusion: Moral expansiveness and the special case of allyship

2018 ◽  
Vol 41 ◽  
Author(s):  
Daniel Crimston ◽  
Matthew J. Hornsey
Keyword(s):  
General Theory ◽  
Biological Markers ◽  
Natural Environment ◽  
Relevant Dimension ◽  
Special Case

AbstractAs a general theory of extreme self-sacrifice, Whitehouse's article misses one relevant dimension: people's willingness to fight and die in support of entities not bound by biological markers or ancestral kinship (allyship). We discuss research on moral expansiveness, which highlights individuals’ capacity to self-sacrifice for targets that lie outside traditional in-group markers, including racial out-groups, animals, and the natural environment.

INFLUENCE OF INDUCED CARCINOGENESIS ON BIOLOGICAL MARKERS OF ENDOTOXEMIA

2018 ◽  
Vol 14 (63) ◽  
pp. 137
Author(s):  
N. Ye. Lisnychuk ◽  
I. Ya. Andriichuk ◽  
Yu. Ya. Soroka ◽  
M. V. Stravska ◽  
S. I. Yavorska
Keyword(s):  
Biological Markers

Assessment of occupational risk of dust lung diseases using biological markers

2020 ◽  
pp. 550-550
Author(s):  
S. A. Babanov ◽  
D. S. Budash
Keyword(s):  
Biological Markers ◽  
Lung Diseases ◽  
Occupational Diseases ◽  
Occupational Risk ◽  
Definition Of

The article is devoted to the definition of occupational risk in a group of workers with high experience in dust-hazardous industries. The features of homeostasis in occupational diseases of the lungs were revealed

Biomarkers of Acromegaly and Growth Hormone Action

2020 ◽  
Vol 27 (12) ◽  
pp. 1231-1245
Author(s):  
Filippo Maffezzoni ◽  
Teresa Porcelli ◽  
Andrea Delbarba ◽  
Letizia Pezzaioli ◽  
Carlo Cappelli ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Biological Markers ◽  
Clinical Care ◽  
Hormone Deficiency ◽  
Surrogate Outcomes ◽  
Current State ◽  
Growth Hormone Action ◽  
Igf I ◽  
Definition Of

: Biological markers (biomarkers) play a key role in drug development, regulatory approval and clinical care of patients and are linked to clinical and surrogate outcomes. : Both acromegaly and Growth Hormone Deficiency (GHD) are pathological conditions related to important comorbidities that, in addition to having stringent diagnostic criteria, require valid markers for the definition of treatment, treatment monitoring and follow-up. GH and insulin-like growth factor-I (IGF-I) are the main biomarkers of GH action in children and adults while, in acromegaly, both GH and IGF-I are established biomarkers of disease activity. : However, although GH and IGF-I are widely validated biomarkers of GHD and acromegaly, their role is not completely exhaustive or suitable for clinical classification and follow-up. Therefore, new biological markers for acromegaly and GH replacement therapy are strongly needed. : The aim of this paper is to review and summarize the current state in the field pointing out new potential biomarkers for acromegaly and GH use/abuse.

Sign in / Sign up

Export Citation Format

Share Document